Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 43)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Nov-09New Constructs, LLCN/ASTJ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
23-Nov-09Reuters Investment ProfileN/ASt Jude Medical Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)148$169  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169  View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ST JUDE MEDICAL INC5$25  View Abstract
20-Nov-09Stock Traders DailyThomas H. Kee Jr.S&P valuation analysis13$50  View Abstract
Next 20

Brokerage Reports (Showing 1 to 6 of 6)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
13-Nov-09Thomson StreetEventsN/ASTJ - Event Transcript of St. Jude Medical, Inc. conference call, Nov. 12, 2009 / 2:00pm ET7$75  View Abstract
22-Oct-09Brean Murray & Co., Inc.Jose HarescoSTJ: St. Jude Offers an Upbeat Long-term View; Near-term Risks Remain, However4$10  View Abstract
22-Oct-09Brean Murray & Co., Inc.Ryan Worst CFA, Andrey Glukhov CFA, Jose Haresco, Jeremy SussmanMorning Insight (OMPI, STJ, Global Gaming, PENN, WLT)8$254 Stars 4 Stars View Abstract
21-Oct-09Thomson StreetEventsN/ASTJ - Event Brief of St. Jude Medical, Inc. conference call, Oct. 21, 2009 / 8:00am ET23$75  View Abstract
21-Oct-09Thomson StreetEventsN/ASTJ - Event Transcript of St. Jude Medical, Inc. conference call, Oct. 21, 2009 / 8:00am ET22$75  View Abstract
13-Oct-09Duncan-Williams, IncJames TerwilligerInitiation of Coverage With a BUY Rating23$75  View Abstract

Independent Reports (Showing 1 to 10 of 37)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Nov-09New Constructs, LLCN/ASTJ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
23-Nov-09Reuters Investment ProfileN/ASt Jude Medical Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)148$169View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ST JUDE MEDICAL INC5$25View Abstract
20-Nov-09Stock Traders DailyThomas H. Kee Jr.S&P valuation analysis13$50View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.